Clinical and Regulatory Perspectives on Biosimilar Therapies and Intended Copies of Biologics in Rheumatology
Rheumatology International - Germany
doi 10.1007/s00296-016-3444-0
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2016
Authors
Publisher
Springer Science and Business Media LLC